Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7.7Revenue $M13.9Net Margin (%)-80.9Altman Z-Score-4.2
Enterprise Value $M4.8EPS $-5.6Operating Margin %-94.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-80.9Higher ROA y-yY
Price/Book0.210-y EBITDA Growth Rate %-11.0Quick Ratio0.9Cash flow > EarningsY
Price/Sales0.45-y EBITDA Growth Rate %4.3Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-21.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-31.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M3.0ROIC % (ttm)-43.1Gross Margin Increase y-yN

Gurus Latest Trades with KOOL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KOOLKen Fisher 2011-09-30 Sold Out -0.0001%$24 - $42.6
($34.49)
$ 2.57-93%Sold Out0
KOOLKen Fisher 2011-06-30 Buy $38.2 - $49.4
($43.91)
$ 2.57-94%New holding1,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KOOL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


KOOL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Harris KennethFormer Director/Officer 2015-11-10Sell4,043$12-78.58view
Harris KennethFormer Director/Officer 2015-11-03Sell526$12-78.58view
Harris KennethFormer Director/Officer 2015-10-29Sell432$12-78.58view
Plavan Matthew TFormer CEO 2015-09-02Sell864$13.6-81.1view
Rhein Denis MichaelDirector 2014-12-01Sell0$0-81.1view
ENGLE J MELVILLEChairman & CEO 2011-03-10Buy1,125$46-94.41view
ARTILES JORGEVP, Quality/Regulatory Affairs 2010-01-13Buy5$48.8-94.73view
ENGLE J MELVILLECEO 2009-09-25Buy1,250$45.6-94.36view
MCENANY PATRICK JDirector 2009-05-19Buy313$46.4-94.46view
ENGLE J MELVILLECEO 2009-05-12Buy1,250$44-94.16view

Quarterly/Annual Reports about KOOL:

News about KOOL:

Articles On GuruFocus.com
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 11 2011 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 04 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 04 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 09 2009 
THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares Sep 28 2009 
THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares May 12 2009 
THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2009 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 05 2009 

More From Other Websites
Cesca Therapeutics T o Present A Poster At The 2016 Annual Meeting Of The European Society For Blood... Apr 07 2016
Cesca Therapeutics To Present A Poster At The 2016 Annual Meeting Of The European Society For Blood... Mar 31 2016
Cesca Therapeutics’ Indian Subsidiary Expands Cord Blood Banking Services To Additional Hospitals... Mar 30 2016
Cesca Therapeutics Appoints Vascular Surgery Expert Lars Norgren, M.D., Ph.D. to its Clinical... Mar 23 2016
Cesca Therapeutics Appoints Vascular Surgery Expert Lars Norgren, M.D., Ph.D., to its Clinical... Mar 23 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Other Events Mar 21 2016
Cesca Therapeutics to Present at the ARM 4th Annual Cell & Gene Therapy Investor Day Mar 16 2016
Big Chinese investor takes seat on struggling company's board Mar 15 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Mar 10 2016
Cesca Therapeutics Appoints Dr. Xiaochun Xu, Chairman and CEO of Boyalife Group, to Board of... Mar 10 2016
McClatchy plans move to boost share price and stay on NYSE Mar 08 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Mar 04 2016
Cesca Therapeutics Announces 1-for-20 Reverse Split of Common Stock Mar 04 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Mar 02 2016
Cesca Therapeutics Announces 1-for-20 Reverse Split of Common Stock Mar 02 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Termination of a Material Definitive Agreement Mar 01 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Financial Statements and Exhibits Feb 22 2016
CESCA THERAPEUTICS INC. Financials Feb 20 2016
Cesca Therapeutics lowers losses by cutting costs Feb 16 2016
CESCA THERAPEUTICS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination... Feb 16 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)